Fulcrum Therapeutics, Inc. (FULC) Equity Alert: Contact Robbins LLP to Learn about the Fulcrum Therapeutics, Inc. Securities Fraud ...
SAN DIEGO, May 23, 2023 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased Fulcrum Therapeutics, Inc. (NASDAQ: FULC) common stock between March 3, 2022 and March 8, …